Comparison between the Use of Clomiphene Citrate and Clomiphene Citrate with Metformin for Ovulation Induction in Women with Polycystic Ovarian Syndrome

Authors

  • Lina Ramadan Tishreen Journal
  • Safa Salman
  • Hiba Mohammad

Abstract

Background: Polycystic ovary syndrome is the common cause of an ovulatory infertility. The aim of this research is to compare the efficacy of clomiphene citrate combined with Metformin for ovulation induction in women with PCOS.

Materials and Methods: A total of 100 cases with PCOS were studied from December 2018 to December 2019 in Tishreen University Hospital in Lattakia. All of them having chief complain of infertility. They were randomly assigned to receive ovulation induction using clomiphene citrate, 100mg daily for 5 days beginning in the five day of spontaneous or induced mense either alone (Group 1), or in combination with Metformin 1500 mg/day for two months, start a month before the cycle we will use clomiphene citrate in it, and continue in the same dose next month (Group 2).

Results: Ovulation rate was higher in Group 2 than Group 1, however without statistically significantly (70% in Group 2 versus 60% in Group 1). With reference to other outcomes: follicle size, endometrial thickness, cervical score were statistically significantly higher in Group 2 than CC alone.

Conclution: Our data suggest that combination of Clomiphene Citrate with Metformin increase ovulation rates compared with Clomiphene Citrate alone.

Downloads

Published

2020-10-01

How to Cite

1.
رمضان ل, سلمان ص, محمد ه. Comparison between the Use of Clomiphene Citrate and Clomiphene Citrate with Metformin for Ovulation Induction in Women with Polycystic Ovarian Syndrome. Tuj-hlth [Internet]. 2020Oct.1 [cited 2024Nov.24];42(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9854

Issue

Vol. 42 No. 4 (2020): Tishreen University Journal for Research and Scientific Studies - Medical Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 > >>